Cyclin L1 anticorps (AA 351-450)

N° du produit ABIN872995

Cet anticorps Lapin Polyclonal détecte spécifiquement Cyclin L1 dans WB, ELISA, IHC (p), IF (cc), IF (p) et IHC (fro). Il présente une réactivité envers Chimpanzé.

Aperçu rapide pour Cyclin L1 anticorps (AA 351-450) (ABIN872995)

Antigène: Cyclin L1 (CCNL1)

Reactivité: Chimpanzé

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Cyclin L1 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Détail du produit anti-Cyclin L1 anticorps

Épitope: AA 351-450

Réactivité croisée: Chimpanzé

Homologie: Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Chimpanzee

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human Cyclin L/CCNL1

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Détails sur Cyclin L1

Antigène: Cyclin L1 (CCNL1)

Autre désignation: Cyclin L

Sujet:

Synonyms: Ania 6a, BM 001, CCNL 1, CCNL1, CCNL1_HUMAN, Cyclin L ania 6a, Cyclin L, Cyclin L gamma, Cyclin L1, Cyclin-L, Cyclin-L1.

Background: Transcriptional regulator which participates in regulating the pre-mRNA splicing process. Seems to be involved in the regulation of RNA polymerase II (pol II). Functions in association with cyclin-dependent kinases (CDKs) and has a role in the second step of splicing. May be a candidate proto-oncogene in head and neck squamous cell carcinomas (HNSCC). Inhibited by the CDK-specific inhibitor p21.Tissue specificity,Ubiquitous with higher level in thymus. Overexpression in primary tumors of head and neck squamous cell carcinomas (HNSCC).

ID gène: 57018